Results
Filtros
Anvisa blocks advertising of pharmaceutical cannabis products on digital platforms
Preventive action involves imported and national items and reinforces rules for restricted disclosure to doctors and pharmacists
Anvisa bans the sale of cannabis products from company
Measure published in the Official Gazette affects company; resolution prohibits the sale of cannabis products without sanitary registration
STJ highlights completion of most stages to regulate the cultivation of medicinal cannabis
The new deadline extends the time for the government to finalize the regulation of cannabis cultivation for the production of medicines in the country
CBD helps reduce alcohol consumption and encourages healthier habits, studies show
Study indicates that cannabidiol (CBD) reduces compulsive behaviors without causing sedation or impairing mobility
CBD Ban: French Court Decision Could Impact Cannabidiol Industry in Europe
05/18/2020The Court's decision is expected to be delivered starting from September 2020
Minor Cannabinoids: Understanding the Plant's Potential Beyond THC and CBD
Compounds like CBN, CBC, and CBG are gaining prominence in science for their distinct therapeutic properties and role in the entourage effect
Anvisa approves changes in quality control of cannabis products from two pharmaceutical companies
Regulatory agency's approval includes adjustments in testing of products with shelf lives between 18 and 24 months manufactured by Prati-Donaduzzi and Promediol
Future of "cannabis light" in Italy: State Council refers case to EU Court
Luxembourg decision could rewrite Italian rules on cultivation and sale of low-THC hemp
Spain: Pills of ecstasy with record doses of MDMA detected
Energy Control detected in Spain ecstasy pills with MDMA doses exceeding 360 mg, more than double the limit considered high potency by the European Drug Agency
Anvisa approves new cannabis-based product in Brazil
Cannten's extract with 71.33 mg/mL expands medicinal treatment options in the country and receives authorization for commercialization
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Psychedelics in Brazil: advances, challenges, and what you need to know about regulation
Recent study gathers 28 scientific articles and points out the main bioethical advances and challenges in the therapeutic use of psychedelics in Brazil, highlighting the need for regulation, safety, informed consent, and fair access to therapies
Psychedelics in Brazil: Advances, Challenges, and What You Need to Know About Regulation
A recent study compiles 28 scientific articles and highlights the main advances and bioethical challenges in the therapeutic use of psychedelics in Brazil, emphasizing the need for regulation, safety, informed consent, and equitable access to therapies.
Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Justice
STJ decision reinforces federal competence for actions involving unregistered drugs at the regulatory agency
Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Court
STJ decision reinforces federal jurisdiction for actions involving unregistered drugs at the regulatory agency
France Advances with Pharmaceutical Framework for Medical Cannabis
New regulation could make the country a reference in the sector by 2026
Regina Helena Costa: Government complied with the determination on regulation of cannabis cultivation, temporarily
Minister states that measures already taken temporarily prevent delays in the process of regulating industrial hemp in Brazil
After 7 years of trials, Denmark definitively legalizes medicinal cannabis
Denmark has officially approved a law that makes its medicinal cannabis pilot program permanent, integrating it into the national healthcare system. The measure was celebrated as a 'victory for patients'